Comorbidities may offset expected improved survival after transcatheter aortic valve replacement.

Pierre Lantelme Matthieu AubryJacques Chan PengBenjamin RicheGéraud SouteyrandPhilippe JaafarMuriel RabilloudBrahim Harbaoui Olivier MüllerBenoit CossetMattia PagnoniThibaut Manigold

Published in: European heart journal open (2022)

The study showed that, beyond a given comorbidity burden (as assessed by CAPRI and Charlson scores), the probability of death within a year was high and poorly reduced by TAVR. This indicates the futility of TAVR in patients in the poor prognosis category.

Keyphrases

transcatheter aortic valve replacement
poor prognosis
aortic stenosis
aortic valve
ejection fraction
long non coding rna
end stage renal disease
newly diagnosed
peritoneal dialysis
prognostic factors
heart failure
patient reported outcomes
risk factors
left ventricular